Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
What's Driving Kodal Minerals Into The Spotlight Among UK Lithium Stocks?
Lithium Stocks

What's Driving Kodal Minerals Into The Spotlight Among UK Lithium Stocks?

Highlights,Kodal Minerals (AIM:KOD) has attracted renewed investor attention as one of the more advanced lithium developers on London's junior market,The company's project in Mali continues to be a key focus point for its development story,Interest in Kod...

What's Driving Rio Tinto and Its Peers Back Into Focus?
Market updates

What's Driving Rio Tinto and Its Peers Back Into Focus?

Highlights,Rio Tinto is drawing renewed investor attention as copper and gold miners gain favour across global markets.,The diversified miner's exposure to iron ore, copper and aluminium continues to shape how it is perceived relative to peers.,Shifting c...

Why Is Rolls-Royce Holdings [LSE:RR.] Suddenly Back Under The Microscope?
Market updates

Why Is Rolls-Royce Holdings [LSE:RR.] Suddenly Back Under The Microscope?

Highlights,Rolls-Royce Holdings has confirmed an expansion of its Raynesway manufacturing site to widen submarine reactor production capacity.,The move is tied to long-term UK and allied naval nuclear propulsion commitments, reinforcing the group's defenc...

Are BAE Systems And Babcock International Jumping On Fresh Defence Momentum?
Top Stories

Are BAE Systems And Babcock International Jumping On Fresh Defence Momentum?

Highlights,BAE Systems and Babcock International remain central names within the UK's aerospace and defence engineering complex.,Ongoing naval and land systems programme activity continues to keep both companies in market conversations.,Sector-wide attent...

Why Are Melrose Industries And Smiths Group Under The Microscope Right Now?
Top Stories

Why Are Melrose Industries And Smiths Group Under The Microscope Right Now?

Highlights,Melrose Industries and Smiths Group are being compared closely as representative names within UK diversified industrial engineering.,Melrose Industries' aerospace-focused portfolio continues to anchor its market narrative following its restruct...

Why Is Land Securities Suddenly Back In London's Property Conversation?
Market updates

Why Is Land Securities Suddenly Back In London's Property Conversation?

Highlights,Land Securities is drawing renewed investor interest as commercial property sentiment shows signs of improvement.,The real estate investment trust's office and retail portfolio mix remains central to how the market frames its outlook.,Broader r...

Why Are Persimmon And Taylor Wimpey In The Rate Crosshairs Again?
Market updates

Why Are Persimmon And Taylor Wimpey In The Rate Crosshairs Again?

Highlights,Persimmon and Taylor Wimpey remain closely watched as mortgage market conditions continue to shape housebuilder sentiment.,Both companies' build rates and land pipeline strategies are drawing attention amid shifting housing demand patterns.,Ana...

Why Is Balfour Beatty Suddenly On National Grid's Contract Radar?
Market updates

Why Is Balfour Beatty Suddenly On National Grid's Contract Radar?

Highlights,Balfour Beatty has secured further roles within National Grid's ongoing electricity transmission investment programme.,The infrastructure contractor's positioning within grid modernisation work continues to shape its market narrative.,National ...

Is AstraZeneca Quietly Rewriting Its Regulatory Story This Week?
Healthcare Stocks

Is AstraZeneca Quietly Rewriting Its Regulatory Story This Week?

Highlights,AstraZeneca has registered a fresh run of regulatory progress across several therapeutic areas, keeping the stock in investor conversations.,The pharmaceutical major's pipeline breadth continues to anchor its position among London's most closel...

Why Is GSK Suddenly Back On London's Deal-Watch Radar?
Healthcare Stocks

Why Is GSK Suddenly Back On London's Deal-Watch Radar?

Highlights,GSK has featured in a cluster of regulatory and deal-related headlines that have kept the stock actively discussed this week.,Defensive healthcare positioning appears to be regaining favour among London investors navigating an uncertain macro b...